157 related articles for article (PubMed ID: 33983584)
1. Patient-Derived Xenograft Models for Ovarian Cancer.
Tran TM; Ho GY; Chu S
Methods Mol Biol; 2024; 2806():187-196. PubMed ID: 38676803
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
[TBL] [Abstract][Full Text] [Related]
3. A Humanized Patient-Derived Xenograft Model for Pancreatic Cancer.
Lundy J
Methods Mol Biol; 2024; 2806():91-100. PubMed ID: 38676798
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with engraftment success of patient-derived xenografts of breast cancer.
Lee J; Lee G; Park HS; Jeong BK; Gong G; Jeong JH; Lee HJ
Breast Cancer Res; 2024 Mar; 26(1):49. PubMed ID: 38515107
[TBL] [Abstract][Full Text] [Related]
5. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
Sengal AT; Pollock PM
Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
[TBL] [Abstract][Full Text] [Related]
6. The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer.
Lewis MT; Caldas C
Cold Spring Harb Perspect Med; 2024 Apr; 14(4):. PubMed ID: 38052483
[TBL] [Abstract][Full Text] [Related]
7. Orthotopic and metastatic tumour models in preclinical cancer research.
Stribbling SM; Beach C; Ryan AJ
Pharmacol Ther; 2024 May; 257():108631. PubMed ID: 38467308
[TBL] [Abstract][Full Text] [Related]
8. Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes.
Al-Hamaly MA; Turner LT; Rivera-Martinez A; Rodriguez A; Blackburn JS
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768609
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in breast cancer cell line research.
Sharma MP; Shukla S; Misra G
Int J Cancer; 2024 May; 154(10):1683-1693. PubMed ID: 38230499
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX).
Zhuang Y; Grainger JM; Vedell PT; Yu J; Moyer AM; Gao H; Fan XY; Qin S; Liu D; Kalari KR; Goetz MP; Boughey JC; Weinshilboum RM; Wang L
NPJ Breast Cancer; 2021 Jun; 7(1):79. PubMed ID: 34145270
[TBL] [Abstract][Full Text] [Related]
11. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer Research.
Witt BL; Tollefsbol TO
Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137912
[TBL] [Abstract][Full Text] [Related]
12. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
[TBL] [Abstract][Full Text] [Related]
13. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
Guillen KP; Fujita M; Butterfield AJ; Scherer SD; Bailey MH; Chu Z; DeRose YS; Zhao L; Cortes-Sanchez E; Yang CH; Toner J; Wang G; Qiao Y; Huang X; Greenland JA; Vahrenkamp JM; Lum DH; Factor RE; Nelson EW; Matsen CB; Poretta JM; Rosenthal R; Beck AC; Buys SS; Vaklavas C; Ward JH; Jensen RL; Jones KB; Li Z; Oesterreich S; Dobrolecki LE; Pathi SS; Woo XY; Berrett KC; Wadsworth ME; Chuang JH; Lewis MT; Marth GT; Gertz J; Varley KE; Welm BE; Welm AL
Nat Cancer; 2022 Feb; 3(2):232-250. PubMed ID: 35221336
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived xenograft models in cancer therapy: technologies and applications.
Liu Y; Wu W; Cai C; Zhang H; Shen H; Han Y
Signal Transduct Target Ther; 2023 Apr; 8(1):160. PubMed ID: 37045827
[TBL] [Abstract][Full Text] [Related]
15. The chick embryo chorioallantoic membrane patient-derived xenograft (PDX) model.
Ribatti D
Pathol Res Pract; 2023 Mar; 243():154367. PubMed ID: 36774760
[TBL] [Abstract][Full Text] [Related]
16. The combination of breast cancer PDO and mini-PDX platform for drug screening and individualized treatment.
Cui Y; Ran R; Da Y; Zhang H; Jiang M; Qi X; Zhang W; Niu L; Zhou Y; Zhou C; Tang X; Wang K; Yan Y; Ren Y; Dong D; Zhou Y; Wang H; Gong J; Hu F; Zhao S; Zhang H; Zhang C; Yang J
J Cell Mol Med; 2024 May; 28(9):e18374. PubMed ID: 38722288
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Xenograft Models in Breast Cancer Research.
Na D; Moon HG
Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
[TBL] [Abstract][Full Text] [Related]
19. Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy.
Kim S; Shin D; Min A; Kim M; Na D; Lee HB; Ryu HS; Yang Y; Woo GU; Lee KH; Lee DW; Kim TY; Lee C; Im SA; Kim JI
J Transl Med; 2021 Jan; 19(1):7. PubMed ID: 33407601
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
